Pfizer Q1 Results
- BSE: 500680
- NSE: PFIZER
- ISIN: INE182A01018
- Sector: Major Drugs
BSE
4,608.35
-89.15 (-1.90%)
-89.15 (-1.90%)Volume1.10 K
Updated: Fri 13 Mar, 2026 | 15:26:14
NSE
4,623.00-72.00 (-1.53%)
-72.00 (-1.53%)Volume15.86 K
Updated: Fri 13 Mar, 2026 | 15:45:02
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Pfizer Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 407.44 | 380.81 | 6.99% | 399.97 | 1.87% |
| Depreciation/ Amortization | 14.41 | 16.40 | -12.13% | 14.60 | -1.30% |
| Operating Income | 195.61 | 211.10 | -7.34% | 162.89 | 20.09% |
| Net Income | 191.75 | 330.94 | -42.06% | 150.71 | 27.23% |
| Other Operating Expenses Total | 85.98 | 79.02 | 8.81% | 93.31 | -7.86% |
| Net Income Before Taxes | 259.53 | 425.80 | -39.05% | 202.62 | 28.09% |
| Total Revenue | 603.05 | 591.91 | 1.88% | 562.86 | 7.14% |
| Selling/ General/ Admin Expenses Total | 95.82 | 82.91 | 15.57% | 91.37 | 4.87% |
| Diluted Normalized EPS | 41.91 | 42.99 | -2.52% | 32.94 | 27.23% |